Last 12 months
Inside the activity.
1 purchase rows · 19 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 2 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 13 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 23, 2022 Filed Feb 26, 2022 01:49 UTC |
Neville EverettEVP, Strategy and Business Dev
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 10,865 | $0.00 Strike: $227.02 | $0.00 |
DisclosureSEC source: 0001225208-22-003487 · doc4.xml · derivative · entry 2 Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,865 Underlying: Common Stock, $.01 Par Value · 10,865 shares Expires 2032-02-23 F2 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2023. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 01:49 UTC |
Neville EverettEVP, Strategy and Business Dev
|
GrantCommon Stock, $.01 Par Value | 2,423 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003487 · doc4.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,221 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2023. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 01:48 UTC |
Jones Nicole SEVP, General Counsel
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 15,753 | $0.00 Strike: $227.02 | $0.00 |
DisclosureSEC source: 0001225208-22-003485 · doc4.xml · derivative · entry 3 Jones Nicole S · CIK 0001492663 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,753 Underlying: Common Stock, $.01 Par Value · 15,753 shares Expires 2032-02-23 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2023. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 01:48 UTC |
Jones Nicole SEVP, General Counsel
|
GrantCommon Stock, $.01 Par Value | 3,513 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003485 · doc4.xml · nonDerivative · entry 1 Jones Nicole S · CIK 0001492663 · EVP, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,775 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2023. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 01:48 UTC |
Evanko Brian CEVP, Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 21,297 | $0.00 Strike: $227.02 | $0.00 |
DisclosureSEC source: 0001225208-22-003484 · doc4.xml · derivative · entry 3 Evanko Brian C · CIK 0001722909 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,297 Underlying: Common Stock, $.01 Par Value · 21,297 shares Expires 2032-02-23 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2023. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 01:48 UTC |
Evanko Brian CEVP, Chief Financial Officer
|
GrantCommon Stock, $.01 Par Value | 4,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003484 · doc4.xml · nonDerivative · entry 1 Evanko Brian C · CIK 0001722909 · EVP, Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,178 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2023. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 01:48 UTC |
Eder Noelle KEVP, CIO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 14,124 | $0.00 Strike: $227.02 | $0.00 |
DisclosureSEC source: 0001225208-22-003483 · doc4.xml · derivative · entry 3 Eder Noelle K · CIK 0001691704 · EVP, CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,124 Underlying: Common Stock, $.01 Par Value · 14,124 shares Expires 2032-02-23 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2023. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 01:48 UTC |
Eder Noelle KEVP, CIO
|
GrantCommon Stock, $.01 Par Value | 3,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003483 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · EVP, CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,677 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2023. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 01:48 UTC |
Cordani DavidDirector · Chair, President & CEO
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 57,284 | $0.00 Strike: $227.02 | $0.00 |
DisclosureSEC source: 0001225208-22-003482 · doc4.xml · derivative · entry 5 Cordani David · CIK 0001318751 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,284 Underlying: Common Stock, $.01 Par Value · 57,284 shares Expires 2032-02-23 F4 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2023. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 01:48 UTC |
Cordani DavidDirector · Chair, President & CEO
|
GrantCommon Stock, $.01 Par Value | 12,775 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003482 · doc4.xml · nonDerivative · entry 1 Cordani David · CIK 0001318751 · Director · Chair, President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 152,752 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2023. F2 · balance_after: Reflects the transfer by the Reporting Person of 238,430 shares of common stock to a grantor retained annuity trust on November 18, 2021 and the transfer by the Reporting Person's grantor retained annuity trust of 104,736 shares of common stock in respect of the payment of an annual annuity to the Reporting Person pursuant to the terms of the grantor retained annuity trust on January 10, 2022. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 01:48 UTC |
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 2,470 | $0.00 Strike: $227.02 | $0.00 |
DisclosureSEC source: 0001225208-22-003481 · doc4.xml · derivative · entry 3 Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,470 Underlying: Common Stock, $.01 Par Value · 2,470 shares Expires 2032-02-23 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2023. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 01:48 UTC |
Agoglia Hoeltzel Mary TSVP Tax & Chief Acct. Officer
|
GrantCommon Stock, $.01 Par Value | 551 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003481 · doc4.xml · nonDerivative · entry 1 Agoglia Hoeltzel Mary T · CIK 0001467807 · SVP Tax & Chief Acct. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,167.024 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2023. Read SEC document |
| February 04, 2022 Filed Feb 8, 2022 19:27 UTC |
BERG CHARLESPres, Govt Programs & Sr Advsr
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 61,683 | $0.00 Strike: $218.10 | $0.00 |
DisclosureSEC source: 0001225208-22-001654 · doc4.xml · derivative · entry 1 BERG CHARLES · CIK 0001111804 · Pres, Govt Programs & Sr Advsr 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,683 Underlying: Common Stock, $.01 Par Value · 61,683 shares Expires 2032-02-04 Read SEC document |
| January 12, 2022 Filed Jan 13, 2022 23:14 UTC |
Neville EverettEVP, Strategy and Business Dev
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 17 | $0.00 Strike: $176.66 | $0.00 |
DisclosureSEC source: 0001225208-22-000738 · doc4.xml · derivative · entry 5 Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 Par Value · 17 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. F2 · derivative.exercise_date: This option was granted on March 4, 2015. The option vested in three equal annual installments on February 28, 2016, February 28, 2017 and February 28, 2018. Read SEC document |
| January 12, 2022 Filed Jan 13, 2022 23:14 UTC |
Neville EverettEVP, Strategy and Business Dev
|
Exercise / conversionCommon Stock, $.01 Par Value | 17 | $176.66 | $3,003.15 |
DisclosureSEC source: 0001225208-22-000738 · doc4.xml · nonDerivative · entry 3 Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,798 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 23:14 UTC |
Neville EverettEVP, Strategy and Business Dev
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 175 | $0.00 Strike: $176.66 | $0.00 |
DisclosureSEC source: 0001225208-22-000738 · doc4.xml · derivative · entry 4 Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17 Underlying: Common Stock, $.01 Par Value · 175 shares Expires 2025-03-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. F2 · derivative.exercise_date: This option was granted on March 4, 2015. The option vested in three equal annual installments on February 28, 2016, February 28, 2017 and February 28, 2018. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 23:14 UTC |
Neville EverettEVP, Strategy and Business Dev
|
SaleCommon Stock, $.01 Par Value | 175 | $240.00 | $42,000.00 |
DisclosureSEC source: 0001225208-22-000738 · doc4.xml · nonDerivative · entry 2 Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,781 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. Read SEC document |
| January 11, 2022 Filed Jan 13, 2022 23:14 UTC |
Neville EverettEVP, Strategy and Business Dev
|
Exercise / conversionCommon Stock, $.01 Par Value | 175 | $176.66 | $30,914.73 |
DisclosureSEC source: 0001225208-22-000738 · doc4.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,956 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:32 UTC |
Neville EverettEVP, Strategy and Business Dev
|
SaleCommon Stock, $.01 Par Value | 4,800 | $229.49 | $1,101,552.00 |
DisclosureSEC source: 0001225208-22-000493 · doc4.xml · nonDerivative · entry 1 Neville Everett · CIK 0001641142 · EVP, Strategy and Business Dev 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,781 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 4, 2021. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 22:06 UTC |
Sanford Paul AEVP Operations
|
Tax withholdingCommon Stock, $.01 Par Value | 129 | $216.29 | $27,901.41 |
DisclosureSEC source: 0001225208-21-015197 · doc4.xml · nonDerivative · entry 1 Sanford Paul A · CIK 0001886769 · EVP Operations 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,408 F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 17:14 UTC |
Ryan CynthiaEVP, CHRO
|
OtherCommon Stock, $.01 Par Value | 1,531.2061 | $216.60 | $331,654.34 |
DisclosureSEC source: 0001225208-21-015129 · doc4.xml · nonDerivative · entry 1 Ryan Cynthia · CIK 0001877352 · EVP, CHRO 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Disclosed balance after: 1,637.6796 F1 · balance_after: Includes shares acquired through ongoing participation in Cigna's 401(k) Plan. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:35 UTC |
Hathi NeeshaDirector
|
GrantCommon Stock, $.01 Par Value | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014395 · doc4.xml · nonDerivative · entry 1 Hathi Neesha · CIK 0001879974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 471 Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:36 UTC |
FOSS ERIC JDirector
|
GrantCommon Stock, $.01 Par Value | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014404 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,016 Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:36 UTC |
DeLaney William J IIIDirector
|
GrantCommon Stock, $.01 Par Value | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014403 · doc4.xml · nonDerivative · entry 1 DeLaney William J III · CIK 0001384151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,106 Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:36 UTC |
WISEMAN ERIC CDirector
|
GrantPhantom Stock Units · Derivative | 173 | $191.90 | $33,198.70 |
DisclosureSEC source: 0001225208-21-014401 · doc4.xml · derivative · entry 2 WISEMAN ERIC C · CIK 0001237851 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,184 Underlying: Common Stock, $.01 Par Value · 173 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F2 · balance_after: Includes 28 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferred Compensation Plan for Directors of Cigna Corporation. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:36 UTC |
WISEMAN ERIC CDirector
|
GrantCommon Stock, $.01 Par Value | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014401 · doc4.xml · nonDerivative · entry 1 WISEMAN ERIC C · CIK 0001237851 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,260 Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:36 UTC |
ZARCONE DONNA FDirector
|
GrantCommon Stock, $.01 Par Value | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014402 · doc4.xml · nonDerivative · entry 1 ZARCONE DONNA F · CIK 0001243083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,673 F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 34 and 107 of Cigna's proxy statement filed with the SEC on March 19, 2021. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:36 UTC |
Ross Kimberly A.Director
|
GrantCommon Stock, $.01 Par Value | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014400 · doc4.xml · nonDerivative · entry 1 Ross Kimberly A. · CIK 0001536350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,614 Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:36 UTC |
PARTRIDGE JOHNDirector
|
GrantCommon Stock, $.01 Par Value | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014399 · doc4.xml · nonDerivative · entry 1 PARTRIDGE JOHN · CIK 0001319897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,790 Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:35 UTC |
McClellan Mark B.Director
|
GrantCommon Stock, $.01 Par Value | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014398 · doc4.xml · nonDerivative · entry 1 McClellan Mark B. · CIK 0001567006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,211 Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:35 UTC |
MAZZARELLA KATHLEEN MDirector
|
GrantCommon Stock, $.01 Par Value | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014397 · doc4.xml · nonDerivative · entry 1 MAZZARELLA KATHLEEN M · CIK 0001273233 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,211 Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:35 UTC |
HARRIS ISAIAH JRDirector · Chairman of the Board
|
GrantCommon Stock, $.01 Par Value | 299 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014394 · doc4.xml · nonDerivative · entry 1 HARRIS ISAIAH JR · CIK 0001202287 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,015 F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 34 and 107 of Cigna's proxy statement filed with the SEC on March 19, 2021. Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:35 UTC |
Kurian GeorgeDirector
|
GrantCommon Stock, $.01 Par Value | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014396 · doc4.xml · nonDerivative · entry 1 Kurian George · CIK 0001586813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 880 Read SEC document |
| November 30, 2021 Filed Dec 2, 2021 23:35 UTC |
Granger ElderDirector
|
GrantCommon Stock, $.01 Par Value | 247 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-014393 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,733 Read SEC document |
| November 19, 2021 Filed Nov 23, 2021 23:01 UTC |
Manders Matthew GPres, Government and Solutions
|
Tax withholdingCommon Stock, $.01 Par Value | 1,081 | $213.65 | $230,955.65 |
DisclosureSEC source: 0001225208-21-014116 · doc4.xml · nonDerivative · entry 1 Manders Matthew G · CIK 0001480601 · Pres, Government and Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 43,488 F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 23:35 UTC |
Cordani DavidDirector · President & CEO
|
GiftCommon Stock, $.01 Par Value | 39,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-013127 · doc4.xml · nonDerivative · entry 2 Cordani David · CIK 0001318751 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust Disclosed balance after: 39,795 F1 · balance_after: Reflects a transfer from a terminating grantor retained annuity trust to a trust for the benefit of certain of Mr. Cordani's family members. Read SEC document |
| October 13, 2021 Filed Oct 15, 2021 23:35 UTC |
Cordani DavidDirector · President & CEO
|
GiftCommon Stock, $.01 Par Value | 39,795 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-013127 · doc4.xml · nonDerivative · entry 1 Cordani David · CIK 0001318751 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Indirect · By GRAT Disclosed balance after: 237,221 F1 · balance_after: Reflects a transfer from a terminating grantor retained annuity trust to a trust for the benefit of certain of Mr. Cordani's family members. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 21:21 UTC |
Eder Noelle KEVP, CIO
|
Tax withholdingCommon Stock, $.01 Par Value | 768 | $207.07 | $159,029.76 |
DisclosureSEC source: 0001225208-21-012427 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · EVP, CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,527 F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| September 01, 2021 Filed Sep 2, 2021 22:05 UTC |
Hathi NeeshaDirector
|
GrantCommon Stock, $.01 Par Value | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-011987 · doc4.xml · nonDerivative · entry 1 Hathi Neesha · CIK 0001879974 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 224 Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 21:55 UTC |
ZARCONE DONNA FDirector
|
GrantCommon Stock, $.01 Par Value | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-011986 · doc4.xml · nonDerivative · entry 1 ZARCONE DONNA F · CIK 0001243083 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,426 F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 34 and 107 of Cigna's proxy statement filed with the SEC on March 19, 2021. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 21:55 UTC |
Ross Kimberly A.Director
|
GrantCommon Stock, $.01 Par Value | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-011985 · doc4.xml · nonDerivative · entry 1 Ross Kimberly A. · CIK 0001536350 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,367 Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 21:55 UTC |
McClellan Mark B.Director
|
GrantCommon Stock, $.01 Par Value | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-011983 · doc4.xml · nonDerivative · entry 1 McClellan Mark B. · CIK 0001567006 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,964 Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 21:55 UTC |
PARTRIDGE JOHNDirector
|
GrantCommon Stock, $.01 Par Value | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-011984 · doc4.xml · nonDerivative · entry 1 PARTRIDGE JOHN · CIK 0001319897 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,543 Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 21:55 UTC |
HARRIS ISAIAH JRDirector · Chairman of the Board
|
GrantCommon Stock, $.01 Par Value | 271 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-011977 · doc4.xml · nonDerivative · entry 1 HARRIS ISAIAH JR · CIK 0001202287 · Director · Chairman of the Board 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,716 F1 · balance_after: The reporting person's economic interest in Cigna securities also includes hypothetical shares of common stock, the value of which is tied directly to the value of Cigna stock. Under the rules of the Securities and Exchange Commission (SEC), Table I excludes these hypothetical shares because they are settled in cash, rather than Cigna stock, upon separation from service. For more information regarding these securities, please see the reporting person's Section 16 filings for Cigna and pages 34 and 107 of Cigna's proxy statement filed with the SEC on March 19, 2021. Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 21:55 UTC |
MAZZARELLA KATHLEEN MDirector
|
GrantCommon Stock, $.01 Par Value | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-011982 · doc4.xml · nonDerivative · entry 1 MAZZARELLA KATHLEEN M · CIK 0001273233 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,964 Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 21:55 UTC |
Kurian GeorgeDirector
|
GrantCommon Stock, $.01 Par Value | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-011981 · doc4.xml · nonDerivative · entry 1 Kurian George · CIK 0001586813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 633 Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 21:55 UTC |
Granger ElderDirector
|
GrantCommon Stock, $.01 Par Value | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-011980 · doc4.xml · nonDerivative · entry 1 Granger Elder · CIK 0001625579 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,486 Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 21:55 UTC |
DeLaney William J IIIDirector
|
GrantCommon Stock, $.01 Par Value | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-011976 · doc4.xml · nonDerivative · entry 1 DeLaney William J III · CIK 0001384151 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,859 Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 21:55 UTC |
FOSS ERIC JDirector
|
GrantCommon Stock, $.01 Par Value | 224 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-011979 · doc4.xml · nonDerivative · entry 1 FOSS ERIC J · CIK 0001197007 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,769 Read SEC document |
| August 31, 2021 Filed Sep 2, 2021 21:55 UTC |
WISEMAN ERIC CDirector
|
GrantPhantom Stock Units · Derivative | 157 | $211.65 | $33,229.05 |
DisclosureSEC source: 0001225208-21-011978 · doc4.xml · derivative · entry 2 WISEMAN ERIC C · CIK 0001237851 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,983 Underlying: Common Stock, $.01 Par Value · 157 shares Expires not disclosed F1 · security: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_price: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.exercise_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F1 · derivative.expiration_date: Under the Deferred Compensation Plan of 2005 for Directors of Cigna Corporation ("Deferral Plan"), directors may elect to defer the payment of the cash and/or common stock portion of their retainers beyond the designated payment date. The phantom stock units described in Table II represent the voluntary deferral of a portion of the reporting person's cash retainer into the hypothetical Cigna stock fund under the Deferral Plan. Each phantom stock unit is the economic equivalent of one share of Cigna common stock and will be settled in cash. F2 · balance_after: Includes 28 phantom stock units acquired pursuant to a dividend reinvestment feature of the Deferred Compensation Plan for Directors of Cigna Corporation. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.